Fundraising Fox
Codon Capital
Venture capitalActively deployingSan Francisco · 1 people tracked
Find your way into Codon Capital
Sign up to see every warm intro you have to Codon Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Codon Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Codon Capital is a venture fund manager based in San Francisco. SEC filings show 2 venture funds on record, most recently Codon Innovation Fund I, LP ($15M offering) filed June 2026.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 1 people
from public directories
What they invest in
from 5 of 5 portfolio companiesBiotech ×5Healthtech ×3Deep Tech ×2AgTech ×1Data & Infrastructure ×1Medical Devices ×1
HQs:United States×5
Investments · 5 tracked
founders shown can be your intro pathBy year:2022 · 12020 · 12019 · 12018 · 14 dated
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)inDaniel Lin-Arlow(Founder)Jared Ellefson(Founder)
Co-investorsCarbon SiliconCerberus VenturesDauntless VenturesFifty YearsJude GomilaMetaplanet+12 more
Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity.
BiotechHealthtechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)inNeela Patel(Executive Officer)inDiane Hollenbaugh(Executive Officer)in
BoardSamuel Bjork(Director)inMonique Schiersing(Director)inJohn McKearn(Director)in
Co-investorsRiverVest Venture PartnersRoche Venture FundVivo Capital3x5 PartnersDigitalis Ventures
Clear Labs develops fully automated next-generation sequencing (NGS) platforms that process genomic data into insights for research and surveillance applications across infectious disease, food safety, and oncology.
BiotechData & InfrastructureDeep TechHealthtechMedical DevicesSan Carlos, US
Sasan Amini(Founder)inRamin Khaksar(Founder)inEdward Fan(Executive Officer)inBrodie Flanders(Executive Officer, Director)Kazutaka Ohno(Executive Officer)Farzad Naimi(Executive Officer, Director)
Co-investorsMenlo VenturesKhosla VenturesNimble VenturesAlumni VenturesCastor VenturesDentsu Ventures+15 more
Portfolio company acquired by Roche.
BiotechSeattle, US
John Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)
BoardJohn McKearn(Director)inKarl Handelsman(Director)
Co-investorsDigitalis VenturesRiverVest Venture Partners3x5 PartnersRoche Venture Fund
Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics.
AgTechBiotechEmeryville, US
Alvin Tamsir(Founder)inKarsten Temme(Founder)inAlvin Tamsir, Ph.D.(Chief Science Officer & Co-Founder)Karsten Temme, Ph.D.(Chief Innovation Officer and Co-Founder)Chris Abbott(Chief Executive Officer)in
BoardRoger Wyse(Director)in
Co-investorsBreakthrough Energy VenturesCongruent VenturesDCVC (Data Collective)G2 Venture PartnersK3 VenturesK3V Ventures+10 more
Exits · 1
1 acquisitionsGood Therapeuticsacq. by Roche
Portfolio news
latest coverage across their companiesPivot Bio · pivotbio.com · Jul 1, 2026
Ansa Biotechnologies · finsmes.com · Oct 2, 2025
Bonum Therapeutics · biospace.com · Jun 10, 2025
Frequently asked questions
- How many investments has Codon Capital made?
- Codon Capital has 5 tracked investments, 1 of which have exited.
- Where is Codon Capital located?
- Codon Capital is headquartered in San Francisco, US.
Co-investors · 6
Digitalis Ventures invests in solutions to unmet needs in biomedicine and health, backing biotechnology and technology-enabled companies across human health and animal health.
Roche Venture Fund is a corporate venture arm that invests in early-stage biotech and diagnostics companies across more than 10 countries, with a portfolio exceeding 30 portfolio companies. The fund is headquartered in Basel, Switzerland.
RiverVest Venture Partners is a life sciences venture capital firm that invests in biotechnology and medical companies, working with entrepreneurs to advance therapeutic and medical innovations.
Felicis is a venture capital firm that backs early-stage founders, investing primarily at Seed and Series A across artificial intelligence, cybersecurity and defense, global resilience and energy, and health and bio.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Firms observed investing alongside Codon Capital, from public investor directories. Shared companies are the overlap with Codon Capital's recorded portfolio.